HomeAI · summaries
Storia in 19 fonti
‘Pandora’s box’: FDA peptide votes could open the door to more unproven drugs
An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists over a lack of data.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
- ·
npr.org
Peptides get their regulatory closeup
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular…
